Pharmaceuticals, Biotechnology and Life Sciences
WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL–Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will participate in the Barclays Global Healthcare…
A rich history of providing early clinical research services to the pharmaceutical industry has proven Celerion a leader in helping…
— Edasalonexent Global Phase 3 PolarisDMD Trial in Duchenne Muscular Dystrophy Top-Line Results Expected in Q4 2020 — — Conference…
CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results from the TOURMALINE-MM2 study designed…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that today’s scheduled in-person presentation at the Barclays Global Healthcare Conference in…
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that Clay Siegall, Ph.D., President and Chief Executive Officer, will participate in…
Top-line data readouts of global Phase 3 program for vadadustat on track for Q2 of 2020 and mid-2020 Company extends…
– Oral Hereditary Angioedema Franchise Phase 2 Clinical Trials on Track – CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–$KALV–KalVista Pharmaceuticals, Inc.…
One-year results from the OPEN WATER trial published in the Journal of Clinical Medicine REDWOOD CITY, Calif.–(BUSINESS WIRE)–#Aquablation—PROCEPT BioRobotics Corporation,…
New Structure Increases Customer Focus, Agility and Growth Opportunities BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc., a leading diagnostic company in lung cancer,…